MesoPher showed promising survival in peritoneal mesothelioma

Amphera announces a positive opinion of the European Medicines Agency on the granting of orphan medicinal product designation for MesoPher in pancreatic cancer

Alligator Bioscience & Amphera Announce Last Patient Treated in mitazalimab-MesoPher REACTIVE-2 Phase 1 Study in Pancreatic Cancer

Amphera announces clinical updates of MesoPher cell therapy

Last patient completed follow-up period in Phase II/III study of Amphera’s MesoPher cell therapy in mesothelioma

Amphera’s MesoPher cell therapy demonstrates favourable safety and promising survival in a phase II clinical trial in resected pancreatic cancer

First patient enrolled in ENSURE study in resected mesothelioma